Bionano Genomics
Stock Forecast, Prediction & Price Target
Bionano Genomics Financial Estimates
Bionano Genomics Revenue Estimates
Bionano Genomics EBITDA Estimates
Bionano Genomics Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $17.98M N/A | $27.80M 54.61% | $36.11M 29.90% | Avg: $49.05M Low: $46.62M High: $51.80M avg. 35.83% | Avg: $74.30M Low: $71.32M High: $77.41M avg. 51.46% | Avg: $101.63M Low: $97.54M High: $105.87M avg. 36.76% | Avg: $138.73M Low: $133.16M High: $144.52M avg. 36.50% |
Net Income
% change YoY
| $-72.43M N/A | $-132.59M -83.05% | $-232.49M -75.33% | Avg: $-67.85M Low: $-45.41M High: $-18.78M avg. 70.81% | Avg: $-52.61M Low: $-12.24M High: $-11.00M avg. 22.46% | Avg: $-6.48M Low: $-6.84M High: $-6.14M avg. 87.66% | Avg: $-1.02M Low: $-1.08M High: $-971.02K avg. 84.21% |
EBITDA
% change YoY
| $-76.92M N/A | $-130.41M -69.53% | $-213.60M -63.78% | Avg: $-49.05M Low: $-51.80M High: $-46.62M avg. 77.03% | Avg: $-74.30M Low: $-77.41M High: $-71.32M avg. -51.46% | Avg: $-101.63M Low: $-105.87M High: $-97.54M avg. -36.76% | Avg: $-138.73M Low: $-144.52M High: $-133.16M avg. -36.50% |
EPS
% change YoY
| -$2.62 N/A | -$4.58 -74.80% | -$6.81 -48.68% | Avg: -$0.98 Low: -$1.33 High: -$0.55 avg. 85.60% | Avg: -$0.34 Low: -$0.36 High: -$0.32 avg. 65.30% | Avg: -$0.19 Low: -$0.2 High: -$0.18 avg. 44.11% | Avg: -$0.03 Low: -$0.03 High: -$0.03 avg. 84.21% |
Operating Expenses
% change YoY
| $80.97M N/A | $137.64M 69.98% | $224.81M 63.32% | Avg: $144.35M Low: $137.19M High: $152.43M avg. -35.78% | Avg: $218.65M Low: $209.87M High: $227.79M avg. 51.46% | Avg: $299.04M Low: $287.03M High: $311.54M avg. 36.76% | Avg: $408.21M Low: $391.82M High: $425.27M avg. 36.50% |
FAQ
What is Bionano Genomics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 66.28% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -45.41M, average is -67.85M and high is -18.78M.
What is Bionano Genomics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 40.14% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is $46.62M, average is $49.05M and high is $51.80M.
What is Bionano Genomics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 69.81% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.33, average is -$0.98 and high is $-0.55.
What is the best performing analyst?
In the last twelve months analysts have been covering Bionano Genomics stock. The most successful analyst is Mark Massaro.